Optimized formulation of multivesicular liposomes loaded with oleanolic acid enhanced anticancer effect in vitro

Area of Science:

• Oncology
• Nanotechnology
• Pharmacology

Background:

• Hepatocellular carcinoma (HCC) metastasis is a primary cause of patient mortality.
• Oleanolic acid (OA) demonstrates potential in suppressing HCC invasion by down-regulating myocyte enhancer factor-2.
• Multivesicular liposomes (MVLs) loaded with OA (OA-MVLs) are known to inhibit HCC cell survival, growth, and angiogenesis.

Purpose of the Study:

• To optimize OA-MVLs formulation using central composite design and response surface methodology.
• To evaluate the in vitro efficacy of optimized OA-MVLs in inhibiting HCC cell survival, adhesion, migration, and invasion.
• To assess the selective toxicity of OA-MVLs towards HCC cells compared to normal liver cells.

Main Methods:

• Central composite design and response surface methodology were employed for OA-MVL formulation optimization.
• Human HCC cell lines (SMMC-7721 and HepG2) were treated with varying doses of OA-MVLs and OA.
• In vitro assays were conducted to measure cellular survival, adhesion, migration, and invasion.

Main Results:

• Optimized OA-MVLs significantly reduced HCC cell adhesion, migration, and invasion in vitro.
• OA-MVLs demonstrated significant inhibition of HCC cell survival at 160 µmol/L.
• OA-MVLs exhibited no significant inhibition of normal liver cell vitality.

Conclusions:

• Optimized OA-MVLs effectively inhibit the in vitro survival, adhesion, invasion, and metastasis of HCC cells.
• The study provides a foundation for developing novel preventive and therapeutic strategies for HCC.
• Further research is needed to elucidate the precise mechanisms underlying OA-MVL action in HCC.